SCHEMBL21552913

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL26031612	0.92	DUT (0.33)	DGAT1DUTKLKB1
	SCHEMBL21564590	0.86	DUT (0.35)	DUT
	SCHEMBL21564447	0.86	DUT (0.34)	DUT
	SCHEMBL21564589	0.86	DUT (0.34)	DUT
	SCHEMBL21552905	0.85	DUT (0.32)	DGAT1DUTKLKB1
	SCHEMBL21564586	0.85	DUT (0.34)	DUT
	SCHEMBL21564651	0.84	DUT (0.35)	DUTLMNA
	SCHEMBL21552998	0.84	DGAT1 (0.35)	DGAT1OPRM1OPRD1OPRK1OGFRL1
	SCHEMBL23257999	0.83	GBA1 (0.33)	OPRM1OPRD1OGFRL1DUT
	SCHEMBL21564578	0.82	DUT (0.32)	DUT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.